Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/16/2022
Organon Acquires Bayer's Contraceptive Products Marvelon and Mercilo...
2/9/2022
Zerun Bio and Walvax to Get Additional CEPI Funding for Vaccine to Pro...
1/14/2022
NMPA Announces Package Insert Revision of Cimetidine Injectable Formul...
1/12/2022
BioNTech Remains Committed to Seeking China Approval for COVID-19 Vacc...
1/7/2022
NMPA Approves MSD's Letermovir and Eli Lilly's Abemaciclib in China
12/23/2021
Luye Grants Genscience Chinese Commercialization Rights of Rivastigmin...
12/23/2021
Pfizer Gains Chinese Approval of ADC Drug Besponsa
12/21/2021
Pfizer Wins Chinese BLA Approval of Inotuzumab Ozogamicin for BCP-ALL
12/20/2021
Novartis and BeiGene Expands Collaboration to BeiGene's TIGIT Inhibito...
12/17/2021
Data Snapshot – The Landscape of Innovative Biologics in China
12/15/2021
New Study: China Healthcare under Remaking in Digital Era
12/15/2021
Chinese Telemedicine Stocks Feel the Pain as Tougher Rules Loom (WSJ)
12/14/2021
Everest Med and Providence Therapeutics Join Hands to Co-develop Vacci...
12/13/2021
Billionaire's Bet on Pfizer Vaccine for China Fails to Pay Off (Bloomb...
12/8/2021
Three Chinese Biopharma Firms to Start Producing Russian Covid-19 Vacc...
12/6/2021
Rhythm Enters Licensing Deal with RareStone to Commercialize Rare Obes...
12/6/2021
SoftBank Reportedly in Investment Talks with Chinese mRNA Vaccine Firm...
11/30/2021
Clover Gets Another $36.9M from CEPI for Covid-19 Vaccine Development
11/24/2021
Pfizer Sues Employee for Allegedly Stealing Covid-19 Vaccine Secrets
11/19/2021
CDE Solicits Comments for the Technical Guidance for Clinical Research...
11/11/2021
NMPA Hosts Meeting on Drug, Medical Device, Cosmetic Regulation in Chi...
11/11/2021
Everest Med and Gilead Announce P2b Study of Sacituzumab Govitecan in ...
11/10/2021
South China Province Plans $94 Million HPV Vaccination Pilot Program
11/8/2021
Ascentage and Pfizer Enter Clinical Trial Agreement to Evaluate Lisaft...
11/8/2021
Half of Top 20 Pharma MNCs Participate CIIE, Showing Continued Commitm...
11/5/2021
Roche Showcases Cutting-Edge Healthcare Innovation Solutions at CIIE
11/3/2021
China Online Medicine Shares Tumble as Beijing Clarifies Rules
10/29/2021
NMPA Announces Package Insert Revision of Zoledronic Acid Injection
10/28/2021
NHC Releases the Draft Rules for Internet Diagnosis and Treatment Regu...
10/26/2021
WHO Clears Chinese HPV Vaccine in Global Battle against Cervical Cance...
Page:
7
/
68
Total number of articles:
2025
:
[First]
[<<]
[5]
[6]
[7]
[8]
[9]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit